MedTrace Logo

Development of an Advisory System for Glycemic Control During the Menstrual Cycle in Patient With Type 1 Diabetes

NCT01653210 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 15

Last updated 2020-04-08

Study results available
· View outcomes & findings →

Summary

This overall research goal will be to develop a mobile-based module to improve glycemic control during the menstrual cycle in women with Type 1 diabetes mellitus (T1DM). This module will run on an Android Operating System (OS) and will be available as: (i) a stand-alone application and (ii) an important additional component to a larger system, the Diabetes Assistant (DiAs) - a mobile-based medical platform for diabetes applications. This proposal aims to build one such application or module targeting the improvement of diabetes control in younger women who experience glucose variation related to their menstrual cycle.

Conditions

  • Type 1 Diabetes Mellitus

Sponsors & Collaborators

  • LifeScan

    collaborator INDUSTRY

  • University of Virginia

    lead OTHER

Principal Investigators

  • Sue A. Brown, MD · University of Virginia

Eligibility

Min Age
18 Years
Max Age
55 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-08-31
Primary Completion
2013-06-30
Completion
2013-09-30

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01653210 on ClinicalTrials.gov